更新欧洲药品质量管理局对缬沙坦中杂质的检测活动

2018-08-22 08:44:29.0

欧洲药品质量监督局继续调查和研究其从2018年7月1日开始的关于缬沙坦中活性物质的NDMA检测。


Update on EDQM’s actions following detection of impurity in valsartan

2018-08-22 08:44:29.0

The EDQM is continuing the investigations and actions which started in July 2018 to address the issue related to the detection of N-nitrosodimethylamine (NDMA) in a source of active substance valsartan.